Medtronic, Covidien unveil joint integration team

Covidien ($COV) and Medtronic ($MDT) announced more than 45 people will join a newly created team to tackle integration issues during their merger. The employees come from both companies. The teams are meant to preserve momentum for both Covidien and Medtronic, optimize joint operations, forward innovations and create dual solutions. More

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.